Repligen Corporation

S&P 500

RGEN/Healthcare · Medical Instruments & Supplies/NASDAQ

Stock Price

$145.23

Stock Price$145.23P/E145.1MCap7.1BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

Dividend Safety Rating

RGEN does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About Repligen Corporation

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems to support the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Headquartered in Waltham, Massachusetts, it serves biopharmaceutical drug developers, contract development and manufacturing organizations (CDMOs), and other life science companies across North America, Europe, and Asia Pacific. The company offers products in four main categories: filtration and fluid management, its largest segment; chromatography, including OPUS pre-packed columns and high-performance resins like AVIPure HiPer for viral vectors; proteins, such as Protein A ligands and affinity chromatography components; and process analytics, featuring slope spectroscopy systems like SoloVPE and FlowVPE. Repligen's technologies enable purification, cell culture growth, and process monitoring, addressing key needs in biologics production for next-generation modalities like gene therapy.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$100.99 - $175.77

Earnings & Profitability

RGEN earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

—

Next Payment Date

—

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

RGEN Dividend Calculator

Number of Shares

Total Investment

$14,523.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is RGEN's current dividend yield?

Repligen Corporation (RGEN) currently has a dividend yield of 0.00%, based on a stock price of $145.23 and an annual dividend of $0.00.

When is RGEN's next dividend payment date?

RGEN's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does RGEN pay in dividends per year?

Repligen Corporation pays dividends unknown. Annual dividend data is not yet available.

Has RGEN been increasing its dividend?

Repligen Corporation has grown its dividend at a 5-year CAGR of —.

Is RGEN's dividend safe?

Repligen Corporation has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.

How is RGEN's Dividend Safety Rating calculated?

The Dividend Safety Rating evaluates Repligen Corporation's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track RGEN Dividends with OnlyDividends

What will RGEN actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.